Upper Limb Telerehabilitation With Virtual Reality in Multiple Scleros
The Effect of a Telerehabilitation Virtual Reality Intervention on Functional Upper Limb Activities in People With Multiple Sclerosis
What it found
A paper reports the results; we have not read it yet. See Papers below.
What was tested
Treatment tested
- Telerehab VR intervention
What it measured
Main measures
Change in Nine Hole Peg Test (9HPT)
Pre-intervention (T0, baseline), post-intervention (T1, +8 weeks from baseline)
Disability progressionArm and hand function
Other measures (3)
Action Research Arm Test (ARAT)
Pre-intervention (T0, baseline), post-intervention (T1, +8 weeks from baseline), 1 month follow-up (T2, +12 weeks from baseline)
Arm and hand functionManual Ability Measure-36 (MAM-36)
Pre-intervention (T0, baseline), post-intervention (T1, +8 weeks from baseline), 1 month follow-up (T2, +12 weeks from baseline)
Arm and hand functionValue of "Impression of change" parameter
Pre-intervention (T0, baseline), post-intervention (T1, +8 weeks from baseline), 1 month follow-up (T2, +12 weeks from baseline)
Arm and hand function
Who could take part
MS (type not specified) · 25 to 60
Show the full criteria
Inclusion criteria
1. diagnosis of MS according to the revised McDonald Criteria 2017; 2. aged 25-60 years old; 3. an Expanded Disability Status Scale score ≥6; 4. an ability to understand and execute simple instructions; 5. a cut-off score of >0.5 pegs/s(=18s) on the NHPT (selected due to its high discriminative and predictive ability in distinguishing ADL independence in pwMS).
Exclusion criteria
1. orthopedic and other neurological disorders affecting upper limb movements (e.g., epileptic seizures); 2. contra-indication to physical activity (e.g., heart failure, severe osteoporosis); 3. moderate or severe cognitive impairments as indicated by the Mini-Mental State Examination score \<21; 4. pregnancy (self-reported); 5. severe uncorrected visual deficits; 6. MS clinical relapse or treatment with corticosteroid therapy within 90 days prior to enrollment; 7. started or stopped a disease-modifying therapy for MS within 90 days prior to enrollment; 8. patients who received a course of physical or occupational therapy (home, outpatient or inpatient) within the past 30 days; 9. other treatments that could influence the effects of the interventions
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
This study aims to investigate the effectiveness of a home-based telerehabilitation program specifically designed for upper limbs, based on Virtual Reality (VR) in individuals affected by Multiple Sclerosis.
Papers
Loading reviews and guidelines…
History
Started
Dec 2020
Main results due
Sept 2021
Finished
Sept 2022